why choose us

First received: June 01, 2026

Clinical Trial: A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Adult

Study Type: INTERVENTIONAL


Official Title: An Open-label, Randomized, Single-dose, Two-Cohort, Two-Period, Crossover Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Ad

Brief Summary: This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects

Read more